245 related articles for article (PubMed ID: 15052802)
21. von Willebrand factor and thrombotic thrombocytopenic purpura.
Raife TJ; Montgomery RR
Curr Opin Hematol; 2000 Sep; 7(5):278-83. PubMed ID: 10961577
[TBL] [Abstract][Full Text] [Related]
22. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
[TBL] [Abstract][Full Text] [Related]
23. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.
Vesely SK; George JN; Lämmle B; Studt JD; Alberio L; El-Harake MA; Raskob GE
Blood; 2003 Jul; 102(1):60-8. PubMed ID: 12637323
[TBL] [Abstract][Full Text] [Related]
24. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Moake JL
Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
[TBL] [Abstract][Full Text] [Related]
25. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura. Current perspectives on EHEC, complement mutations and ADAMTS13].
Karpman D
Lakartidningen; 2008 Apr 9-15; 105(15):1096-101. PubMed ID: 18561752
[No Abstract] [Full Text] [Related]
26. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura.
Tsai HM
J Am Soc Nephrol; 2003 Apr; 14(4):1072-81. PubMed ID: 12660343
[TBL] [Abstract][Full Text] [Related]
27. [Pathophysiology of thrombotic microangiopathies: current understanding].
Coppo P; Veyradier A; Durey MA; Fremeaux-Bacchi V; Scrobohaci ML; Amesland F; Bussel A
Ann Med Interne (Paris); 2002 May; 153(3):153-66. PubMed ID: 12218898
[TBL] [Abstract][Full Text] [Related]
28. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.
George JN; Vesely SK; Terrell DR
Semin Hematol; 2004 Jan; 41(1):60-7. PubMed ID: 14727260
[TBL] [Abstract][Full Text] [Related]
29. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
Yagi H
Rinsho Byori; 2005 Jul; 53(7):630-8. PubMed ID: 16104532
[TBL] [Abstract][Full Text] [Related]
30. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
Moake JL
Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
[TBL] [Abstract][Full Text] [Related]
31. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases.
Veyradier A; Obert B; Houllier A; Meyer D; Girma JP
Blood; 2001 Sep; 98(6):1765-72. PubMed ID: 11535510
[TBL] [Abstract][Full Text] [Related]
32. Severe deficiency of the specific von Willebrand factor-cleaving protease (ADAMTS 13) activity in a subgroup of children with atypical hemolytic uremic syndrome.
Veyradier A; Obert B; Haddad E; Cloarec S; Nivet H; Foulard M; Lesure F; Delattre P; Lakhdari M; Meyer D; Girma JP; Loirat C
J Pediatr; 2003 Mar; 142(3):310-7. PubMed ID: 12640381
[TBL] [Abstract][Full Text] [Related]
33. Plasma levels of the von Willebrand factor-cleaving protease in physiological and pathological conditions in children.
Kavakli K; Canciani MT; Mannucci PM
Pediatr Hematol Oncol; 2002; 19(7):467-73. PubMed ID: 12217192
[TBL] [Abstract][Full Text] [Related]
34. Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy.
Robson WL; Tsai HM
Pediatrics; 2002 Feb; 109(2):322-5. PubMed ID: 11826215
[No Abstract] [Full Text] [Related]
35. ADAMTS13 and TTP.
Zheng X; Majerus EM; Sadler JE
Curr Opin Hematol; 2002 Sep; 9(5):389-94. PubMed ID: 12172456
[TBL] [Abstract][Full Text] [Related]
36. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
Furlan M; Robles R; Morselli B; Sandoz P; Lämmle B
Thromb Haemost; 1999 Jan; 81(1):8-13. PubMed ID: 10348715
[TBL] [Abstract][Full Text] [Related]
37. Not known from ADAM(TS-13)--novel insights into the pathophysiology of thrombotic microangiopathies.
Wolf G
Nephrol Dial Transplant; 2004 Jul; 19(7):1687-93. PubMed ID: 15128885
[No Abstract] [Full Text] [Related]
38. Thrombotic thrombocytopenic purpura: a simpler diagnosis at last?
Mannucci PM
Thromb Haemost; 1999 Nov; 82(5):1380-1. PubMed ID: 10595621
[No Abstract] [Full Text] [Related]
39. Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura.
Tsai HM
Arterioscler Thromb Vasc Biol; 2003 Mar; 23(3):388-96. PubMed ID: 12615692
[TBL] [Abstract][Full Text] [Related]
40. Autosomal recessive inheritance of von Willebrand factor-cleaving protease deficiency.
te Loo DM; Levtchenko E; Furlan M; Roosendaal GP; van den Heuvel LP
Pediatr Nephrol; 2000 Aug; 14(8-9):762-5. PubMed ID: 10955922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]